GlobeNewswire
Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
📈
AI Sentiment
Highly Positive
8/10
Collegium Pharmaceutical Inc. News
Latest updates and market news for COLL
5 news
Dec 17 - Dec 23, 2025
Page 1
Zacks
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Is Strong Q3 Beat And Higher Guidance Altering The Investment Case For Collegium Pharmaceutical (COLL)?
📈
AI Sentiment
Highly Positive
8/10
Share this news page